G. Bodoky
0000-0002-5659-2020
Publication & Citation Trends
Most Cited Works
Publications
284 total
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial PDF
Cited by 3,616
OpenAlex
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer PDF
Cited by 3,395
OpenAlex
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
Cited by 1,175
OpenAlex
Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study
Cited by 943
OpenAlex
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
Cited by 2,435
OpenAlex
Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer PDF
Cited by 599
OpenAlex
Panitumumab–FOLFOX4 Treatment and <i>RAS</i> Mutations in Colorectal Cancer PDF
Cited by 2,232
OpenAlex
Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial PDF
Cited by 838
OpenAlex
Research Topics
Colorectal Cancer Treatments and Studies
(143)
Gastric Cancer Management and Outcomes
(74)
Pancreatic and Hepatic Oncology Research
(52)
Hepatocellular Carcinoma Treatment and Prognosis
(43)
Cancer Treatment and Pharmacology
(42)
Frequent Co-Authors
Affiliations
Semmelweis University
Roche (Switzerland)
University of Verona
Amgen (United States)
State University of New York